Signaling Pathways between Cancer and Immune Cells

Dear Colleagues,

Despite the consistent advancement in cancer diagnosis and treatment, cancer remains the second leading cause of death globally, accounting for one in six deaths. The immune system plays a vital role in the onset and progression of cancer, and the immune response to cancer can be innate or adaptive. Therefore, immune manipulation for cancer treatment is emerging as an effective therapeutic strategy. Recent advancements, including successful therapies targeting program cell death protein-1 (PD1) expressed in immune cells or programmed death-ligand 1 (PD-L1) expressed in cancer cells, are a testament to the effectiveness of immune regulation in cancer treatment. The intercellular communication between cancer cells and immune cells is well established. The intercellular communications between cancer and immune cells are regulated by myriad signaling pathways activated in cancer cells, resulting in perturbation of signaling pathways in immune cells. This Special Issue focuses on bringing together research focused on understanding signaling pathways between cancer and immune cells that would provide more in-depth insight into cancer onset and progression.

This Special Issue invites research articles on the basic, translational, or clinical aspects of signaling pathways between cancer and immune cells to provide a comprehensive understanding of cancer.

Dr. Anuraag Shrivastav
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.